Evaxion Biotech A/S (EVAX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Evaxion Biotech A/S

    NASDAQ: EVAX · Real-Time Price · USD
    5.43
    0.69 (14.56%)
    At close: Oct 03, 2025, 3:59 PM
    5.30
    -2.39%
    After-hours: Oct 03, 2025, 07:48 PM EDT

    Evaxion Biotech A/S Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -10.55M -22.13M -23.17M -24.53M
    Depreciation & Amortization
    		 607.02K 615K 571K 344K
    Stock-Based Compensation
    		 357K 479K 942K 1.38M
    Other Working Capital
    		 -303K -48.7K -2.28M 21K
    Other Non-Cash Items
    		 -3.06M 2.76M -243K -171K
    Deferred Income Tax
    		 -813K -984K -998K -190K
    Change in Working Capital
    		 520K 1.56M -2.88M 1.24M
    Operating Cash Flow
    		 -12.94M -17.69M -25.77M -21.93M
    Capital Expenditures
    		 4.69 -87K -292K -1.36M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -3K -6K n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a 24.01K 29.95K
    Other Investing Acitivies
    		 n/a 133.00 -13 48.00
    Investing Cash Flow
    		 -3K -93K -268K -1.33M
    Debt Repayment
    		 -1.14M -632K 7.42M -289K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -2.29M 2.15M n/a -3.76M
    Financial Cash Flow
    		 13.13M 10.69M 7.85M 49.8M
    Net Cash Flow
    		 369K -7.6M -18.98M 26.33M
    Free Cash Flow
    		 -12.94M -17.78M -26.07M -23.29M

    Add to Watchlist